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Abstract
Introduction: Acute ST-segment elevation myocardial infarction secondary to atherosclerotic plaque rupture is a
common medical emergency. This condition is effectively managed with percutaneous coronary intervention or
thrombolysis. We report a rare case of acute myocardial infarction secondary to coronary embolisation of valvular
vegetation in a patient with infective endocarditis, and we highlight how the management of this phenomenon
may not be the same.
Case presentation: A 73-year-old British Caucasian man with previous tissue aortic valve replacement was
diagnosed with and treated for infective endocarditis of his native mitral valve. His condition deteriorated in
hospital and repeat echocardiography revealed migration of vegetation to his aortic valve. Whilst waiting for
surgery, our patient developed severe central crushing chest pain with associated anterior ST segment elevation on
his electrocardiogram. Our patient had no history or risk factors for ischaemic heart disease. It was likely that
coronary embolisation of part of the vegetation had occurred. Thrombolysis or percutaneous coronary intervention
treatments were not performed in this setting and a plan was made for urgent surgical intervention. However, our
patient deteriorated rapidly and unfortunately died.
Conclusion: Clinicians need to be aware that atherosclerotic plaque rupture is not the only cause of acute myocardial
infarction. In the case of septic vegetation embolisation, case report evidence reveals that adopting the current
strategies used in the treatment of myocardial infarction can be dangerous. Thrombolysis risks intra-cerebral
hemorrhage from mycotic aneurysm rupture. Percutaneous coronary intervention risks coronary mycotic aneurysm
formation, stent infections as well as distal septic embolisation. As yet, there remains no defined treatment modality
and we feel all cases should be referred to specialist cardiac centers to consider how best to proceed.
Introduction
A t h e r o s c l e r o t i cp l a q u er u p t u r ew i t h i nac o r o n a r yv e s s e l
can lead to rapid vessel occlusion and subsequent myo-
cardial ischaemia and necrosis [1]. Risk factors for the
development of atherosclerosis include hypertension,
diabetes mellitus, high cholesterol, a history of smoking,
and a family history of atherosclerotic disease [2]. Cur-
rent treatment involves either percutaneous coronary
intervention (PCI) to relieve the occlusion, or thrombo-
lysis to dissolve the occlusion [3].
There are more rare causes of acute myocardial
infarction (AMI). We present and discuss the case of a
patient with AMI secondary to embolisation of vegeta-
tion sitting on a prosthetic aortic valve in a patient with
confirmed aortic valve infective endocarditis (IE).
Case presentation
A 73-year-old British Caucasian man who had under-
g o n eat i s s u ea o r t i cv a l v er e placement five years pre-
viously was admitted to his local hospital with a two-
week history of breathlessness, general malaise and
night sweats. On examination, he was found to have an
ejection systolic murmur in the aortic area and a pan-
systolic murmur in the mitral area radiating to the
axilla. His white cell count was elevated (15.1 × 10
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9 cells/L) and he had a
raised C-reactive protein level of 101 mg/dL. The results
of three consecutive blood cultures samples were nega-
tive even after five days in the culture media. His trans-
thoracic and trans-oesophageal echocardiogram (ECG)
results demonstrated vegetation involving the native
posterior mitral valve leaflet (Figure 1) with moderate
mitral regurgitation and a moderately stenosed tissue
aortic valve. Vancomycin, Gentamicin and Rifampicin
were given under microbiology guidance. Five days later,
our patient became more unwell, and was found to be
in worsening cardiac failure. A repeat echocardiogram
showed the known vegetation on the mitral valve and
new vegetation on the aortic valve of 1.5 cm (Figure 2)
causing moderate aortic regurgitation. Our patient was
subsequently transferred to our center for valve surgery.
Whilst awaiting surgery, our patient developed severe
central crushing chest pain with associated anterior seg-
ment ST elevation on his ECG (Figure 3). Our patient
had no previous history of angina, and was a non-smo-
ker with no other cardiac risk factors. A coronary angio-
gram performed five years ago prior to his valve surgery
revealed unobstructed coronaries. The most likely expla-
nation for this ST segment elevation myocardial infarc-
tion (STEMI) was coronary embolisation of either part
of the vegetation or thrombus attached to the vegeta-
tion. Thrombolysis is relatively contraindicated in this
scenario. PCI risked mycotic aneurysm formation and
either further systemic or coronary embolisation. There-
fore, urgent surgical intervention was planned; however,
our patient deteriorated rapidly and unfortunately died.
Discussion
Coronary embolisation is a rare cause of AMI and needs
to be considered in patients with atrial fibrillation,
prosthetic heart valves, dilated cardiomyopathy, and IE,
where either thrombus or vegetation can embolize into
the coronary circulation. Although systemic embolisa-
tion can occur in up to 50% of cases of IE [4], coronary
embolisation rate is about 0.3% [5]. There appears to be
an increased risk of embolisation with vegetations that
are > 1 cm in diameter, as in our patient’s case [6]. Suc-
cessful strategies that have been used to manage coron-
ary embolisation in non-endocarditic patients include
thrombolytics [7], PCI and thrombus aspiration [8].
There is no clear evidence available about the best
treatment option for patients with coronary embolisa-
tion in the setting of acute IE [9]. Thrombolytic treat-
ment of septic coronary embolisation is associated
with an increased risk of cerebral vascular hemorrhage
due to bleeding from silent cerebral microinfarctions
or mycotic aneurysms [10]. Indeed AMI caused by sep-
tic embolisation is a relative contraindication to the
use of thrombolytic agents. PCI involves coronary bal-
loon angioplasty and stent deployment, and this risks
mycotic aneurysm formation at the dilatation site. This
occurs as the balloon crushes vegetation against the
vessel wall [11]. Implanting foreign stent material into
an infective site can lead to stent infection, and this
can require stent excision and debridement [12]. In
addition, PCI risks further distal vegetation embolisa-
tion [13]. As reported in a previous case report, ‘the
impulse to follow conventional strategies for coronary
reperfusion should be tempered by thoughts of possi-
ble consequences’ [11].
Surgical intervention in left-sided IE is in fact recom-
mended in the context of systemic embolisation [14].
However, evidence of successful surgical intervention in
the context of coronary embolisation is scarce, with a
Figure 1 Echocardiogram (apical view) showing vegetation in
the native posterior mitral valve leaflet (white arrow). LA = left
atrium; LV = left ventricle; RA = right atrium; RV = right ventricle.
Figure 2 Echocardiogram (parasternal long axis view) showing
large vegetation in the tissue prosthetic aortic valve (white
arrow). LA = left atrium; LV = left ventricle; MV = mitral valve; RV =
right ventricle.
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ary embolectomy [15].
Conclusions
This case report presents a common condition seen in
an uncommon setting. AMI is common, and the man-
agement is well defined and performed by acute physi-
cians and cardiologists. However, in the absence of risk
factors for ischaemic heart disease, clinicians need to
consider alternate causes of AMI.
This is especially important in the case of septic cor-
onary embolisation in patients with IE, as adopting the
current strategies used in the management of myocar-
dial infarction can be dangerous. Where suspicion is
high, care should be urgently transferred to specialist
cardiac centers where both interventional and surgical
skills are available to decide on how best to proceed.
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Figure 3 Electrocardiogram showing ST elevation in V1 to V4 leads.
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